Veradigm | MDRX - Actif À Court Terme





Actif À Court Terme Changement Date
Alcidion AUD 28.52M 4.83M 2025-12
Ambu A/S DKK 3.01B 33M 2026-03
Amplifon EUR 763.04M 321.16M 2025-12
Cardinal Health USD 38.06B 1.17B 2026-03
Centene USD 44.99B 4.62B 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cigna USD 43.03B 4.78B 2026-03
Coloplast 10.3B 155M 2025-12
Computer Programs Systems USD 104.64M 2.07M 2025-12
Convatec Group USD 793.3M 70.6M 2024-12
CVS Health USD 74.82B 103M 2026-03
Diasorin EUR 759.63M 400.63M 2025-06
Elevance Health USD 67.03B 4.03B 2026-03
General Electric Aerospace USD 40.36B 235M 2026-03
Gulf Medical Proj AED 431.22M 55.83M 2025-12
Humana USD 38.08B 5.35B 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Maximus USD 1.51B 85.64M 2026-03
McKesson USD 57.21B 2.49B 2026-03
Med Life RON 695.45M 10.09M 2025-12
Molina Healthcare USD 13.33B 882M 2026-03
Omnicell USD 722.3M 42.23M 2026-03
Oriola-kd EUR 656.9M 42.9M 2025-12
Owens Minor USD 588.5M 40.63M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Rede D'or Sao Luiz BRL 54.78B 1B 2026-03
Siemens Healthineers EUR 14.18B 15M 2026-03
Sonova Holding CHF 1.91B 466.3M 2025-06
Supermax Corporation Bhd MYR 1.08B 116.24M 2025-12
UnitedHealth USD 91.13B 545M 2026-03
Veeva Systems USD 8B 885.78M 2025-12
Veradigm USD 679.65M 131.12M 2022-12
Xerox USD 3.78B 212M 2026-03